UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 433

Sortiert nach

The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses

Frontiers in pharmacology, 2023-02, Vol.14, p.1080117-1080117

2023

Link zum Volltext

Verfügbarkeit prüfen

Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus

Frontiers in genetics, 2022-05, Vol.13, p.869160-869160

2022

Link zum Volltext

Verfügbarkeit prüfen

Thirteen years' experience of pharmacokinetic monitoring and dosing of busulfan: can the strategy be improved?

Therapeutic drug monitoring, 2014-02, Vol.36 (1), p.86

2014

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation

Stroke (1970), 2017-01, Vol.48 (1), p.159-166

2017

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous Determination of Dabigatran, Rivaroxaban, and Apixaban in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry

Therapeutic drug monitoring, 2020-06, Vol.42 (3), p.473

2020

Link zum Volltext

Verfügbarkeit prüfen

Usage of renal function equations to guide prescribing in general medicine

New Zealand medical journal, 2013-09, Vol.126 (1383), p.97-99

2013

Link zum Volltext

Verfügbarkeit prüfen

Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects

British journal of clinical pharmacology, 2011-12, Vol.72 (6), p.985-989

2011

Link zum Volltext

Verfügbarkeit prüfen

Learning More From the Dabigatran Concentrations in the RE-LY Study

Journal of the American College of Cardiology, 2014-06, Vol.63 (24), p.2746-2747

2014

Link zum Volltext

Verfügbarkeit prüfen

The Pharmacokinetics and Pharmacogenetics of the Antiemetic Cyclizine in Palliative Care Patients

Journal of pain and symptom management, 2012-03, Vol.43 (3), p.540-548

2012

Link zum Volltext

Verfügbarkeit prüfen

The effect of routine preoperative interruption of dabigatran therapy on coagulation parameters and dabigatran plasma levels in a mixed surgical population

Anaesthesia and intensive care, 2019-03, Vol.47 (2), p.183-188

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand

British journal of clinical pharmacology, 2023-10, Vol.89 (10), p.3105-3115

2023

Link zum Volltext

Verfügbarkeit prüfen

A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients

Clinical microbiology and infection, 2022-03, Vol.28 (3), p.446.e1-446.e7

2022

Link zum Volltext

Verfügbarkeit prüfen

Four‐year review of New Zealand laboratory infliximab and adalimumab concentration results indicating potential for improved dosing

Internal medicine journal, 2023-11, Vol.53 (11), p.2123-2127

2023

Link zum Volltext

Verfügbarkeit prüfen

Which patients may benefit from dose adjustment of non-vitamin K antagonist oral anticoagulants?

Seminars in thrombosis and hemostasis, 2015-03, Vol.41 (2), p.195

Chin, Paul K L

2015

Link zum Volltext

Verfügbarkeit prüfen

Changes in inpatient medicine prescribing during COVID‐19 lockdown

Internal medicine journal, 2023-06, Vol.53 (6), p.917-922

2023

Link zum Volltext

Verfügbarkeit prüfen

Frequency of pharmacological target attainment with flucloxacillin and cefazolin in invasive methicillin-susceptible Staphylococcus aureus infection: a prospective cohort study in hospitalized patients

International journal of antimicrobial agents, 2023-01, Vol.61 (1), p.106695-106695, Article 106695

2023

Link zum Volltext

Verfügbarkeit prüfen

A nationwide survey on therapeutic drug monitoring of anti‐tumour necrosis factor agents for inflammatory bowel disease

Internal medicine journal, 2021-03, Vol.51 (3), p.341-347

2021

Link zum Volltext

Verfügbarkeit prüfen

Biological variation of thiopurine methyltransferase enzyme activity: when has a significant change taken place?

Annals of clinical biochemistry, 2013-09, Vol.50 (Pt 5), p.473

2013

Link zum Volltext

Verfügbarkeit prüfen

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup

Critical care (London, England), 2021-06, Vol.25 (1), p.201-25, Article 201

2021

Link zum Volltext

Verfügbarkeit prüfen

Determinants of vancomycin nephrotoxicity when administered to outpatients as a continuous 24-hour infusion

International journal of antimicrobial agents, 2020-06, Vol.55 (6), p.105972, Article 105972

2020

Link zum Volltext

Verfügbarkeit prüfen

Extracorporeal treatment for ethylene glycol poisoning: systematic review and recommendations from the EXTRIP workgroup

Critical Care, 2023-02, Vol.27 (1), p.56-56, Article 56

2023

Link zum Volltext

Verfügbarkeit prüfen

A proposal for dose‐adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

British journal of clinical pharmacology, 2014-09, Vol.78 (3), p.599-609

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical decision support in a hospital electronic prescribing system informed by local data: experience at a tertiary New Zealand centre

Internal medicine journal, 2020-10, Vol.50 (10), p.1225-1231

2020

Link zum Volltext

Verfügbarkeit prüfen

Comment on: “Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study”

Clinical pharmacokinetics, 2017-02, Vol.56 (2), p.207-208

2017

Link zum Volltext

Verfügbarkeit prüfen

Letter by Chin et al Regarding Article, “Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis”

Circulation (New York, N.Y.), 2014-11, Vol.130 (22), p.e194-e194

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 433

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(395)
Mit Volltextzugriff
(377)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses

Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus

Thirteen years' experience of pharmacokinetic monitoring and dosing of busulfan: can the strategy be improved?

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation

Simultaneous Determination of Dabigatran, Rivaroxaban, and Apixaban in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry

Usage of renal function equations to guide prescribing in general medicine

Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects

Learning More From the Dabigatran Concentrations in the RE-LY Study

The Pharmacokinetics and Pharmacogenetics of the Antiemetic Cyclizine in Palliative Care Patients

The effect of routine preoperative interruption of dabigatran therapy on coagulation parameters and dabigatran plasma levels in a mixed surgical population

Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand

A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients

Four‐year review of New Zealand laboratory infliximab and adalimumab concentration results indicating potential for improved dosing

Which patients may benefit from dose adjustment of non-vitamin K antagonist oral anticoagulants?

Changes in inpatient medicine prescribing during COVID‐19 lockdown

Frequency of pharmacological target attainment with flucloxacillin and cefazolin in invasive methicillin-susceptible Staphylococcus aureus infection: a prospective cohort study in hospitalized patients

A nationwide survey on therapeutic drug monitoring of anti‐tumour necrosis factor agents for inflammatory bowel disease

Biological variation of thiopurine methyltransferase enzyme activity: when has a significant change taken place?

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup

Determinants of vancomycin nephrotoxicity when administered to outpatients as a continuous 24-hour infusion

Extracorporeal treatment for ethylene glycol poisoning: systematic review and recommendations from the EXTRIP workgroup

A proposal for dose‐adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

Clinical decision support in a hospital electronic prescribing system informed by local data: experience at a tertiary New Zealand centre

Comment on: “Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study”

Letter by Chin et al Regarding Article, “Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis”

Suchergebnisse filtern